Molecule

Gentamicin

Also known as gentamicin sulfate

Available on requestAntibiotics Ophthalmology Dermatology

Presentations: 14
Brands: 1
Manufacturers: 1
Available from stock: 0

Gentamicin is an aminoglycoside antibacterial. It is available as injection, eye drops and ointment for intravenous, intramuscular and ophthalmic use. MedsAcross supplies Gentamicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class: Aminoglycoside Antibacterial
ATC classification: D06AX07 Gentamicin · Antibiotics and antivirals for the skin, subgroup D06A, subgroup D06AXJ01GB03 Gentamicin · Aminoglycoside antibiotic, subgroup J01GBS01AA11 Gentamicin · Eye medicines, subgroup S01A, subgroup S01AAS02AA14 Gentamicin · Anti-infective agentS03AA06 Gentamicin · Anti-infective agent
US FDA first approval: 19 June 1970
EU status: Not recorded
Orphan designation: Not recorded
WHO essential medicine: Not recorded
India (CDSCO): Not yet confirmed against CDSCO approval lists
Routes: Intravenous, Intramuscular, Ophthalmic, Topical
Dosage forms: Injection, Eye drops, Ointment, Ophthalmic solution, Cream, Eye ointment
Identifiers: UNII T6Z9V48IKGRxCUI 1596450CAS 1403-66-3DrugBank DB00798Q422482

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Primary skin infections: Impetigo contagiosa, superficial folliculitis, ecthyma, furunculosis, sycosis barbae, and pyoderma gangrenosum. Secondary skin infections: Infectious eczematoid dermatitis, pustular acne, pustular psoriasis, infected seborrheic dermatitis, infected contact dermatitis (including poison ivy), infected excoriations, and bacterial superinfections of fungal or viral infections. NOTE: Gentamicin Sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections. It is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria.

Source: US FDA prescribing information

Dosing overview

A small amount of Gentamicin Sulfate Ointment USP, 0.1% should be applied gently to lesions three to four times a day. The area treated may be covered with a gauze dressing, if desired. In impetigo contagiosa, the crusts should be removed before application of Gentamicin Sulfate Ointment USP, 0.1% to permit maximum contact between the antibiotic and the infection. Care should be exercised to avoid further contamination of the infected skin. Infected stasis ulcers have responded well to Gentamicin Sulfate under gelatin packing.

Source: US FDA prescribing information

Contraindications

Gentamicin Sulfate Ointment USP, 0.1% is contraindicated in individuals with a history of sensitivity reactions to any of its components.

Source: US FDA prescribing information

Warnings and precautions

Use of topical antibiotics occasionally allows overgrowth of nonsusceptible organisms, including fungi. If this occurs, or if irritation, sensitization, or superinfection develops, treatment with Gentamicin Sulfate Ointment USP, 0.1% should be discontinued and appropriate therapy instituted.

Source: US FDA prescribing information

Side effects

In patients with dermatoses treated with Gentamicin Sulfate, irritation (erythema and pruritus) that did not usually require discontinuance of treatment has been reported in a small percentage of cases. There was no evidence of irritation or sensitization, however, in any of these patients patch-tested subsequently with gentamicin on normal skin. Possible photosensitization has been reported in several patients but could not be elicited in these patients by reapplication of gentamicin followed by exposure to ultraviolet radiation.

Source: US FDA prescribing information

Storage

Store at 20˚C to 25˚C (68˚F to 77˚F).

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

14 presentations of Gentamicin, sorted by availability.

Medicine	Manufacturer	Register	Availability
Gentamicin 80 mg/2 mL injectionIntramuscular, intravenousGeneric name	—	US FDA	Available on request
Gentamicin 3 mg/mL eye dropsOphthalmicGeneric name	—	US FDA	Available on request
Gentamicin 800 mg/20 mL injectionIntramuscular, intravenousGeneric name	—	US FDA	Available on request
Gentamicin 0.1% ointmentTopicalGeneric name	—	US FDA	Available on request
Gentamicin 3 mg/mL ophthalmic solutionOphthalmicGeneric name	—	US FDA	Available on request
Gentamicin 0.1% creamTopicalGeneric name	—	US FDA	Available on request
Gentamicin 20 mg/2 mL injectionIntramuscular, intravenousGeneric name	—	US FDA	Available on request
Gentak 0.3% eye ointmentOphthalmic	Proficient Rx	US FDA	Available on request
Gentamicin 100 mg/100 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Gentamicin 100 mg/50 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Gentamicin 120 mg/100 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Gentamicin 60 mg/50 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Gentamicin 80 mg/100 mL injectionIntravenousGeneric name	—	US FDA	Available on request
Gentamicin 80 mg/50 mL injectionIntravenousGeneric name	—	US FDA	Available on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Gentak

Manufacturers

Proficient Rx1 presentation

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

Register	Status	Source
US FDA	First approved 19 June 1970	Drugs@FDA
EU (EMA)	Not recorded	—
India (CDSCO)	Not yet confirmed against CDSCO approval lists	—
United States	Registered	US FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Gentamicin in public data. This is not a list of approved uses, see the clinical information.

Bubonic plague Campylobacteriosis Chancroid Endocarditis Far East scarlet-like fever Glanders Gram-negative bacterial infection Granuloma inguinale Infectious bone disease Infective endocarditis Listeriosis Pseudomonas infection Sepsis Staphylococcal infection Trench fever Upper respiratory tract infection Urinary tract infection

Questions and answers

Is Gentamicin available for export from India?

Yes, on request. MedsAcross lists 14 presentations of Gentamicin and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Gentamicin have?

The catalogue lists 1 brand names for Gentamicin, including Gentak.

Is Gentamicin approved by the US FDA?

Yes. The US FDA first approved Gentamicin on 19 June 1970, according to Drugs@FDA.

Does Gentamicin need cold chain shipping?

No listed presentation of Gentamicin is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Gentamicin in?

Gentamicin is classified under ATC code D06AX07 (Gentamicin).

References

GENTAMICIN SULFATE prescribing information (Encube Ethicals). U.S. National Library of Medicine, DailyMed. Retrieved 1 October 2026

Request Gentamicin for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.

Request a quote Read the import guides